Patent · US Active

Synergistic combination of neuronal viability factors and uses thereof

US10668129B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Universite Pierre Et Marie Curie (Paris 6) · FR
The Regents of the University of California · US
The Trustees of the University of Pennsylvania · US

Inventors

Thierry Leveillard · Maisons-Alfort, FR
John G. Flannery · Berkeley, US
Xin MEI · Paris, FR
Leah Byrne · Paris, FR
Jose-Alain Sahel · Paris, FR
Emmanuelle CLERIN-LACHAPELLE · Paris, FR
Junwei Sun · Philadelphia, US
Jean Bennett · Via Enrico Fermi, US
Jeannette Bennicelli · Philadelphia, US

Key dates

Filing date	May 20, 2016
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Oct 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the synergistic combination of the short and long Rod-Derived Cone Viability Factors and to methods for treating retinal degenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.